Annual Current Assets
$201.06 M
-$45.62 M-18.49%
31 December 2023
Summary:
Esperion Therapeutics annual total current assets is currently $201.06 million, with the most recent change of -$45.62 million (-18.49%) on 31 December 2023. During the last 3 years, it has fallen by -$144.83 million (-41.87%). ESPR annual current assets is now -41.87% below its all-time high of $345.90 million, reached on 31 December 2020.ESPR Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$307.56 M
-$37.55 M-10.88%
30 September 2024
Summary:
Esperion Therapeutics quarterly total current assets is currently $307.56 million, with the most recent change of -$37.55 million (-10.88%) on 30 September 2024. Over the past year, it has increased by +$89.33 million (+40.93%). ESPR quarterly current assets is now -15.88% below its all-time high of $365.61 million, reached on 31 March 2024.ESPR Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -18.5% | +40.9% |
3 y3 years | -41.9% | +80.2% |
5 y5 years | +41.0% | +21.3% |
ESPR Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -41.9% | at low | -15.9% | +80.2% |
5 y | 5 years | -41.9% | +41.0% | -15.9% | +80.2% |
alltime | all time | -41.9% | >+9999.0% | -15.9% | +4208.5% |
Esperion Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $307.56 M(-10.9%) |
June 2024 | - | $345.11 M(-5.6%) |
Mar 2024 | - | $365.61 M(+81.8%) |
Dec 2023 | $4.73 M(+276.7%) | $201.06 M(-7.9%) |
Sept 2023 | - | $218.23 M(-6.0%) |
June 2023 | - | $232.13 M(-7.4%) |
Mar 2023 | - | $250.60 M(+1.6%) |
Dec 2022 | $1.26 M(-97.6%) | $246.68 M(-5.8%) |
Sept 2022 | - | $261.79 M(+3.7%) |
June 2022 | - | $252.48 M(-13.2%) |
Mar 2022 | - | $290.82 M(-11.6%) |
Dec 2021 | $52.62 M(+614.7%) | $328.97 M(+92.8%) |
Sept 2021 | - | $170.67 M(-38.0%) |
June 2021 | - | $275.17 M(+1.0%) |
Mar 2021 | - | $272.57 M(-21.2%) |
Dec 2020 | $7.36 M(+169.4%) | $345.90 M(+42.5%) |
Sept 2020 | - | $242.80 M(-24.4%) |
June 2020 | - | $321.37 M(+86.2%) |
Mar 2020 | - | $172.63 M(-18.5%) |
Dec 2019 | $2.73 M(+233.7%) | $211.71 M(-16.5%) |
Sept 2019 | - | $253.46 M(-17.5%) |
June 2019 | - | $307.12 M(+30.6%) |
Mar 2019 | - | $235.22 M(+64.9%) |
Dec 2018 | $819.00 K | $142.63 M(-15.2%) |
Sept 2018 | - | $168.21 M(-10.9%) |
June 2018 | - | $188.88 M(-6.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $201.41 M(-1.2%) |
Dec 2017 | $73.91 M(+133.6%) | $203.92 M(-1.4%) |
Sept 2017 | - | $206.82 M(+21.0%) |
June 2017 | - | $170.95 M(-9.1%) |
Mar 2017 | - | $188.01 M(-12.0%) |
Dec 2016 | $31.64 M(-61.0%) | $213.58 M(+0.1%) |
Sept 2016 | - | $213.47 M(+2.1%) |
June 2016 | - | $209.09 M(+6.1%) |
Mar 2016 | - | $197.05 M(-8.1%) |
Dec 2015 | $81.18 M(+121.9%) | $214.39 M(-2.0%) |
Sept 2015 | - | $218.84 M(-3.0%) |
June 2015 | - | $225.71 M(-19.3%) |
Mar 2015 | - | $279.83 M(+162.3%) |
Dec 2014 | $36.58 M(+107.0%) | $106.70 M(+95.5%) |
Sept 2014 | - | $54.58 M(-11.0%) |
June 2014 | - | $61.32 M(+5.2%) |
Mar 2014 | - | $58.28 M(-3.9%) |
Dec 2013 | $17.67 M(>+9900.0%) | $60.62 M(-16.9%) |
Sept 2013 | - | $72.96 M(+276.3%) |
June 2013 | - | $19.39 M(-12.4%) |
Mar 2013 | - | $22.12 M(+209.9%) |
Dec 2012 | $174.00 K(-44.9%) | $7.14 M |
Dec 2011 | $315.70 K(-94.9%) | - |
Dec 2002 | $6.14 M(-12.9%) | - |
Dec 2001 | $7.05 M(+7.9%) | - |
Dec 2000 | $6.54 M(+234.2%) | - |
Dec 1999 | $1.96 M | - |
FAQ
- What is Esperion Therapeutics annual total current assets?
- What is the all time high annual current assets for Esperion Therapeutics?
- What is Esperion Therapeutics annual current assets year-on-year change?
- What is Esperion Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly current assets year-on-year change?
What is Esperion Therapeutics annual total current assets?
The current annual current assets of ESPR is $201.06 M
What is the all time high annual current assets for Esperion Therapeutics?
Esperion Therapeutics all-time high annual total current assets is $345.90 M
What is Esperion Therapeutics annual current assets year-on-year change?
Over the past year, ESPR annual total current assets has changed by -$45.62 M (-18.49%)
What is Esperion Therapeutics quarterly total current assets?
The current quarterly current assets of ESPR is $307.56 M
What is the all time high quarterly current assets for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly total current assets is $365.61 M
What is Esperion Therapeutics quarterly current assets year-on-year change?
Over the past year, ESPR quarterly total current assets has changed by +$89.33 M (+40.93%)